PANEL DISCUSSION – What are the lessons learned from decentralizing – what takeaways do we have as an industry from the last few years

  • Weighing the advantages and disadvantages of having decentralized
  • What do both the sponsor and vendor want to gain from decentralizing trials and how can we balance that
  • Look at the real costs of DCT, does it impact your data quality